On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Extended deadline (from 1 July to 31 July) 2017 for call to submit papers on effectiveness and cost-effectiveness of screening and prevention of infectious diseases among newly arrived migrants in Europe. Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2008: Volume 13/ Issue 11 Article 3
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 13, Issue 11, 13 March 2008
Rapid communications
Isolation of a Vibrio parahaemolyticus pandemic strain from a marine water sample obtained in the northern Adriatic
  1. Department of Pathology, Section of Microbiology, University of Verona, Verona, Italy

Citation style for this article: Caburlotto G, Ghidini V, Gennari M, Tafi MC, Lleo MM. Isolation of a Vibrio parahaemolyticus pandemic strain from a marine water sample obtained in the northern Adriatic. Euro Surveill. 2008;13(11):pii=8068. Available online:


Vibrio parahaemolyticus is a halophilic bacterium capable of causing food- and waterborne gastroenteritis, wound infections, and septicaemia in humans. The wide distribution of V. parahaemolyticus in the marine and estuarine environments is known to depend on the water temperature: it has been suggested that the bacterium might survive in sediments during the winter and be released into the water column in late spring or early summer when the temperature rises to 15°C or higher [1].

The microorganism is frequently isolated from a variety of raw seafood and shellfish. Consumption of raw or undercooked seafood contaminated with V. parahaemolyticus may lead to the development of acute gastroenteritis characterized by diarrhoea, headache, vomiting, nausea, and abdominal cramps. This bacterial species is a common cause of foodborne illnesses in many Asian countries, including China (31.1% of foodborne outbreaks reported between 1991 and 2001), Japan (reported to account for 20–30% of foodborne infection cases from 1981 to 1993) and Taiwan (1,495 cases reported between 1981 and 2003, representing 69% of all bacterial foodborne outbreaks in this period) [2,3,4]. Moreover, it is recognized as the leading cause of human gastroenteritis associated with seafood consumption in the United States [5]. In Europe, the risk of V. parahaemolyticus infections is considered to be very low [6,7] and for this reason the monitoring of this microorganism has been excluded from the most important European infectious disease surveillance networks. However, sporadic outbreaks have been reported in countries such as Spain (important outbreaks reported in 1989, 1999 and 2004) [8] and France (a serious outbreak reported in 1997) [9].

Less commonly, this bacterial species can cause infections in the skin when an open wound is exposed to warm seawater (>15°C). Severe wound infections and septicaemia have also been reported mainly in immunosuppressed, children and aged people. Recently seven cases of skin infections caused by V. parahaemolyticus species have been described in Denmark linked to bathing in the Baltic Sea [10].

V. parahaemolyticus infection has traditionally been associated with two virulence factors – thermostable direct haemolysin (TDH) and TDH-related haemolysin (TRH) [6]. While more than 90% of the clinical isolates present the tdh gene, to date pathogenic strains containing tdh and/or trh genes have been detected with low frequency (usually 0.3 to 3%) in the total V. parahaemolyticus environmental population [11].

During a hospital-based survey in Calcutta, India, a sudden increase in the proportion of infections associated with V. parahaemolyticus serotype O3:K6 was detected [2]. This highly virulent strain accounted for 63% of all V. parahaemolyticus strains isolated from patients in Calcutta between September 1996 and April 1997 and was subsequently obtained in high rates from patients in other southeast Asian countries and from travellers arriving in Japan from this region [12,13]. Increased incidences of gastroenteritis caused by this serovar have been reported in many countries since 1996 [12,13,14]. Therefore, as a result of its rise in incidence with identical phenotypic and genotypic features, this emerging V. parahaemolyticus strain has been termed a ‘pandemic strain’. Currently the so-called ‘pandemic group’ [15] includes the ‘pandemic’ O3:K6 strain and the newly emerged O4:K68, O1:K25, O1:K26, and O1:K untypeable strains.

While all the strains of V. parahaemolyticus are identified by the species-specific genetic markers tlh and toxR genes, ‘pandemic’ V. parahaemolyticus strains can be identified by group-specific GS-PCR based on the sequence variation in the toxRS gene [15]. A strain possessing both tdh and toxRS/new can be considered a ‘pandemic strain’. In addition, most of the ‘pandemic strains’ have a novel open reading frame orf8, which corresponds to a filamentous phage f237 [16].

During a series of sampling campaigns organized within the framework of the international VibrioSea project* and conducted in the north of the Adriatic Sea in the area of the Venetian lagoon from June 2006 to November 2007, a collection of environmental V. parahaemolyticus strains was obtained. They were isolated mainly during the warm season (from May to October) and have been found in water, plankton and sediment samples.

After the biochemical identification, using the Biomérieux API ID system, all the strains were confirmed as V. parahaemolyticus by PCR detection of the species-specific markers, genes tlh and toxR [17]. Screening conducted on the whole collection revealed, in one of the analyzed strains (strain VPeVEpan), the presence of the virulence gene tdh and the ‘pandemic’-specific marker, gene orf8. The presence of each one of these genes was confirmed by PCR with a second pair of primers selected in a different area of the same nucleotide sequence. The strain also tested positive to a group-specific PCR (GS-PCR) conducted with a pair of primers selected in the toxRS gene. The strain was isolated in May 2007 in a marine water sample taken from the coastal site in the locality Caleri, close to the estuary of the Adige and Brenta rivers, 500 m from the coastline). Serological characterization and molecular typing is ongoing and the genes are currently being sequenced in order to compare this strain with other ‘pandemic strains’ of environmental and clinical origin, isolated in Europe and Asia.

On the basis of these findings and the data from the literature, this strain should be considered to have the potential to cause human illness because it carries the three ‘pandemic’ genetic markers. To the best of our knowledge, this is the first strain of V. parahaemolyticus isolated in the Italian coastal environment and the first isolated directly from an environmental water sample in Europe containing the genetic markers characterizing ‘pandemic strains’ (tdh, orf8, toxRS/new). Previously, ‘pandemic strains’ similar to the ones isolated in Asia, had been detected in the Galicia region of Spain [14] and in France [18], yet these strains were in all cases clinical isolates or strains isolated from seafood and not from the environment itself.

The results reported here indicate that the environmental strains belonging to human pathogenic Vibrio species isolated in Europe should be considered as potential carriers of virulence genes including those encountered in ‘pandemic strains’. Because of their pathogenic potential their presence should be placed under surveillance as they could represent a risk for human health.

*The VibrioSea project is an ongoing international research project funded by Centre National d’Etudes Spatiales (CNES) and Institut Pasteur, France.

The authors would like to thank Giorgio Socal, Franco Bianchi, Fabrizio Bernardi and Mauro Bastianini from Istituto di Scienze Marine – Consiglio Nazionale delle Ricerche ( ISMAR-CNR), Venice, Italy, for their help and collaboration in the sampling campaigns during which the described
V. parahaemolyticus strain has been isolated.



  1. Kaneko T, Colwell RR. Ecology of Vibrio parahaemolyticus in Chesapeake Bay. J Bacteriol. 1973;113(1):24-32
  2. Nair GB, Ramamurthy T, Bhattacharya SK, Dutta B, Takeda Y, Sack DA. Global dissemination of Vibrio parahaemolyticus serotype O3:K6 and its serovariants. Clin Microbiol Rev. 2007;20:39-48.
  3. Liu X, Chen Y, Wang X, Ji R. Foodborne disease outbreaks in China from 1992 to 2001 national foodborne disease surveillance system. Wei Sheng Yan Jiu. 2004;33:725-727.
  4. Muramatsu K. Comparison of epidemiological markers for Vibrio parahaemolyticus isolated from food poisoning. Kansenshogaku Zasshi. 1999;73:179-186.
  5. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, Griffin PM, Tauxe RV. Food-related illness and death in the United States. Emerg Infect Dis. 1999;5:607-625.
  6. Yi-Cheng Su and Chengchu Liu. Vibrio parahaemolyticus: A concern of seafood safety. Food Microbiology 2007;24:549-558.
  7. Opinion of the Scientific Committee on Veterinary measures relating to public health on Vibrio vulnificus and Vibrio parahaemolyticus. European Commission, 2001.
  8. Lozano-León A, Torres J, Osorio CR, Martínez-Urtaza J. Identification of tdh-positive Vibrio parahaemolyticus from an outbreak associated with raw oyster consumption in Spain. FEMS Microbiol Lett. 2003,226:281-284.
  9. Robert-Pillot A, Guénolé A, Lesne J, Delesmont R, Fournier JM, Quilici ML. Occurrence of the tdh and trh genes in Vibrio parahaemolyticus isolates from waters and raw shellfish collected in two French coastal areas and from seafood imported into France. Int J Food Microbiol. 2004;91:319-325.
  10. Andersen PH. Infections with seawater bacteria. EPI-NEWS 2006;(26-32):1. Available from:
  11. Nordstrom JL, Vickery MC, Blackstone GM, Murray SL, DePaola A. Development of a multiplex real-time PCR assay with an internal amplification control for the detection of total and pathogenic Vibrio parahaemolyticus bacteria in oysters. Appl. Environ. Microbiol. 2007;73:5840-5847.
  12. Chiou CS, Hsu SY, Chiu SI, Wang TK, Chao CS. Vibrio parahaemolyticus serovar O3:K6 as cause of unusually high incidence of food-borne disease outbreaks in Taiwan from 1996 to 1999. J Clin Microbiol. 2000;38:4621-4625.
  13. Vuddhakul V, Chowdhury A, Laohaprertthisan V, Pungrasamee P, Patararungrong N, Thianmontri P, Ishibashi M, Matsumoto C, Nishibuchi M. Isolation of a pandemic O3:K6 clone of a Vibrio parahaemolyticus strain from environmental and clinical sources in Thailand. Appl Environ Microbiol. 2000;66:2685-2689.
  14. Martinez-Urtaza J, Simental L, Velasco D, DePaola A, Ishibashi M, Nakaguchi Y, Nishibuchi M, Carrera-Flores D, Rey-Alvarez C, Pousa A. Pandemic Vibrio parahaemolyticus O3:K6, Europe. Emerg Infect Dis. 2005;11:1319-1320.
  15. Okura M, Osawa R, Iguchi A, Arakawa E, Terajima J, Watanabe H. Genotypic analyses of Vibrio parahaemolyticus and development of a pandemic group-specific multiplex PCR assay. J Clin Microbiol. 2003;41:4676-4682.
  16. Myers ML, Panicker G, Bej AK. PCR detection of a newly emerged pandemic Vibrio parahaemolyticus O3:K6 pathogen in pure cultures and seeded waters from the Gulf of Mexico. Appl. Environ. Microbiol. 2003;69:2194-2200.
  17. Kim YB, Okuda J, Matsumoto C, Takahashi N, Hashimoto S, Nishibuchi M. Identification of Vibrio parahaemolyticus strains at the species level by PCR targeted to the toxR gene. J. Clin. Microbiol. 1999;37:1173-1177.
  18. Quilici ML, Robert-Pillot A, Picart J, Fournier JM. Pandemic Vibrio parahaemolyticus O3:K6 spread, France. Emerg Infect Dis. 2005;11:1148-1149.


Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.